- iopromide
-
- $0.00 / 1g
-
2024-04-10
- CAS:73334-07-3
- Min. Order: 1g
- Purity: 99.99%
- Supply Ability: 20 tons
- Iopromide
-
- $0.00 / 25KG
-
2023-11-07
- CAS:73334-07-3
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
- Iopromide
-
- $12.00 / 1kg
-
2023-09-18
- CAS:73334-07-3
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 20 tons
|
| | Iopromide Basic information |
| Product Name: | Iopromide | | Synonyms: | 6-triiodo-)-n-methyl-4;shl414c;IOPROMIDE;N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N'-methylbenzene-1,3-dicarboxamide;oproMide;IoproMide SynonyMs: N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-Methoxyacetyl)aMino]-N'-Methylbenzene-1,3-dicarboxaMide;Iopromide, >=98%;magnesium methanide propan-1-ide(1:1:1) | | CAS: | 73334-07-3 | | MF: | C18H24I3N3O8 | | MW: | 791.11 | | EINECS: | 277-385-9 | | Product Categories: | Isotope Labelled Compounds;Amines;Aromatics;Diagnostic;Intermediates & Fine Chemicals;Pharmaceuticals | | Mol File: | 73334-07-3.mol |  |
| | Iopromide Chemical Properties |
| Hazard Codes | N | | Risk Statements | 50/53 | | Safety Statements | 60-61 | | RIDADR | UN 3077 9 / PGIII | | WGK Germany | 3 | | RTECS | CZ2230000 | | HS Code | 2924296000 | | Toxicity | LD50 in mice, rats (g iodine/kg body weight): 16.5, 11.4 i.v. (Muetzel) |
| | Iopromide Usage And Synthesis |
| Description | Iopromide is a non-ionic, water-soluble X-ray contrast agent for intravascular administration. Iopromide can cause acute kidney injury and is used in animal models of contrast-induced nephropathy. | | Chemical Properties | White Solid | | Uses | Labelled Iopromide. Nonionic, injectable radio-contrast medium. Diagnostic aid (radiopaque medium). | | Uses | Contrast molecule | | Definition | ChEBI: A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A
ater soluble x-ray contrast agent for intravascular administration. | | Brand name | Ultravist (Berlex). | | General Description | Iopromide is a low-osmolar,nonionic monomer with 48% bound iodine content. It is indicatedfor use in angiography, excretory urography, andnumerous CT procedures. | | Side effects | Most common adverse reactions (>1%) are headache, nausea, injection site and infusion site reactions, vasodilatation, vomiting, back pain, urinary urgency, chest pain, pain, dysgeusia, and abnormal vision. |
| | Iopromide Preparation Products And Raw materials |
|